Stanley Lapidus

Stanley Lapidus

Direttore/Membro del Consiglio presso LUCID DIAGNOSTICS INC.

Patrimonio netto: 347 514 $ in data 31/05/2026

77 anni
Health Technology
Finance
Commercial Services

Profilo

Stanley N.
Lapidus
was the founder of Helicos Biosciences Corp.
(2003), serving as Lead Independent Director; Cytyc Corp.
(1987), serving as President; EXACT Sciences Corp.
(1995), serving as President and CEO, Chairman; SynapDx Corp.
(2009), serving as President, Chief Executive Officer & Director.
Mr. Lapidus is also the founder of Petri,Synapdx Corp.
(MD)..
Mr. Lapidus is currently Chairman at binx health, inc.
since 2018, Vice Chairman at Lucid Diagnostics, Inc. since 2021, Chairman & Board of Directors at Mirvie, Inc. since 2018, Chairman at Mercy BioAnalytics, Inc., Director at Aushon Biosystems, Inc. since 2017, Member & Board Of Directors at PathAI, Inc. since 2017, Director at Glympse Bio, Inc., Director at Binx Health Ltd., Director at Droplet Biosciences, Inc., Director at Sunbird Bio, Inc. since 2018, Advisor at Flare Capital Management Co. LLC, and Founding Pillar at Pillar Co Management LLC since 2016.
Former positions include Director at Daktari Diagnostics, Inc., Director at Helomics Corp., Lead Independent Director at T2 Biosystems, Inc. from 2008 to 2020, Director at Fractyl Health, Inc., Advisor at Flagship Pioneering, Inc. from 2003 to 2009, Trustee at The Cooper Union for the Advancement of Science & Art from 2002 to 2012, and Advisor at Excel Medical Ventures LLC.
Education includes an undergraduate degree from The Cooper Union for the Advancement of Science & Art, conferred in 1970.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
27/04/2026 337.392 ( 0,17% ) 347 514 $ 31/05/2026

Posizioni attive di Stanley Lapidus

SocietàPosizioneInizio
LUCID DIAGNOSTICS INC. Direttore/Membro del Consiglio 28/07/2021
Direttore/Membro del Consiglio 01/11/2017
Direttore/Membro del Consiglio 01/09/2018
Consulente / Consigliere -
Investitore di Private Equity 01/03/2016
Direttore/Membro del Consiglio -
Presidente -
Presidente 01/06/2018
Direttore/Membro del Consiglio 20/03/2018
░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ -

Precedenti posizioni note di Stanley Lapidus

SocietàPosizioneFine
░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░ ░░░░░ ░░░ ░░░ ░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Stanley Lapidus

Formazione di Stanley Lapidus

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

62

Relazioni di 1° grado

25

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private25

Health Technology

Health Technology

Industrial Services

Health Technology

Finance

Commercial Services

Health Services

Consumer Services

Finance

Health Technology

Health Technology

Commercial Services

Health Technology

Finance

Finance

Technology Services

Health Technology

Commercial Services

Health Technology

Finance

Health Services

Health Technology

Health Technology

Health Services

Health Technology

  1. Mercati
  2. Insiders
  3. Stanley Lapidus
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA